Tiny magnetic microrobots, developed by ETH Zurich, precisely deliver drugs to stroke clots and tumors, achieving a 95% ...
Researchers drilling under a college campus in the 1980s paved the way for an ambitious new project in the Twin Cities.
Insight Molecular Diagnostics Inc. is rated Hold due to upcoming catalysts & pending FDA submission for GraftAssureDx. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback